Current research focuses on three main areas: the association between osteocalcin levels and diabetic complications, the clinical efficacy of drugs or vitamins for osteoporosis in diabetic patients of different ages and sexes, and the potential mechanism of insulin regulation by osteocalcin. This evidence concerns the gene BGLAP and osteoporosis.